News and Trends 25 Jul 2023
Roche and Alnylam to work on RNAi therapeutic to treat hypertension
Roche has announced a partnership with Alnylam to develop and commercialize zilebesiran, an investigational RNAi therapeutic currently in phase 2 for the treatment of hypertension. Hypertension affects more than 1.2…